Cart summary

You have no items in your shopping cart.

RBM14 Antibody (C-term)

Catalog Number: orb1938117

DispatchUsually dispatched within 5-10 working days
$ 140.00
Catalog Numberorb1938117
CategoryAntibodies
DescriptionAffinity Purified Rabbit Polyclonal Antibody (Pab)
Species/HostRabbit
ClonalityPolyclonal
Clone NumberRB17298
Tested applicationsFC, IHC-P, WB
Predicted ReactivityMouse
ReactivityHuman
IsotypeRabbit IgG
Antibody TypePrimary Antibody
Dilution rangeWB: 1:1000, IHC-P: 1:10~50, FC: 1:10~50
Form/AppearancePurified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
ConjugationUnconjugated
MW69492 Da
TargetThis RBM14 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 563-594 amino acids from the C-terminal region of human RBM14.
UniProt IDQ96PK6
NCBINP_001185774.1, NP_001185765.1, NP_006319.1, NP_001185766.1, NP_001185775.1
StorageMaintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
Alternative namesRNA-binding protein 14, Paraspeckle protein 2, PSP
Read more...
NoteFor research use only
Expiration Date12 months from date of receipt.
RBM14 Antibody (C-term)

RBM14 Antibody (C-term) western blot analysis in Jurkat cell line lysates (35 ug/lane). This demonstrates the RBM14 antibody detected the RBM14 protein (arrow).

RBM14 Antibody (C-term)

RBM14 Antibody (C-term) flow cytometric analysis of Jurkat cells (right histogram) compared to a negative control cell (left histogram). FITC-conjugated donkey-anti-rabbit secondary antibodies were used for the analysis.

RBM14 Antibody (C-term)

RBM14 Antibody (C-term) immunohistochemistry analysis in formalin fixed and paraffin embedded human brain tissue followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of RBM14 Antibody (C-term) for immunohistochemistry. Clinical relevance has not been evaluated.